Guidance for design and endpoints of clinical trials in chronic hepatitis B - Report from the 2019 EASL-AASLD HBV Treatment Endpoints Conference‡
書誌事項
- 公開日
- 2020-03
- 権利情報
-
- https://www.elsevier.com/tdm/userlicense/1.0/
- https://www.elsevier.com/legal/tdmrep-license
- DOI
-
- 10.1016/j.jhep.2019.11.003
- 公開者
- Elsevier BV
この論文をさがす
収録刊行物
-
- Journal of Hepatology
-
Journal of Hepatology 72 (3), 539-557, 2020-03
Elsevier BV